Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity.
Ventre KS, Roehle K, Bello E, Bhuiyan AM, Biary T, Crowley SJ, Bruck PT, Heckler M, Lenehan PJ, Ali LR, Stump CT, Lippert V, Clancy-Thompson E, Conce Alberto WD, Hoffman MT, Qiang L, Pelletier M, Akin JJ, Dougan M, Dougan SK. Ventre KS, et al. Among authors: bello e. J Immunol. 2023 Apr 1;210(7):991-1003. doi: 10.4049/jimmunol.2200646. J Immunol. 2023. PMID: 36881882 Free PMC article.
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy.
Quijano-Rubio A, Bhuiyan AM, Yang H, Leung I, Bello E, Ali LR, Zhangxu K, Perkins J, Chun JH, Wang W, Lajoie MJ, Ravichandran R, Kuo YH, Dougan SK, Riddell SR, Spangler JB, Dougan M, Silva DA, Baker D. Quijano-Rubio A, et al. Among authors: bello e. Nat Biotechnol. 2023 Apr;41(4):532-540. doi: 10.1038/s41587-022-01510-z. Epub 2022 Oct 31. Nat Biotechnol. 2023. PMID: 36316485 Free PMC article.
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy.
Qiang L, Hoffman MT, Ali LR, Castillo JI, Kageler L, Temesgen A, Lenehan P, Wang SJ, Bello E, Cardot-Ruffino V, Uribe GA, Yang A, Dougan M, Aguirre AJ, Raghavan S, Pelletier M, Cremasco V, Dougan SK. Qiang L, et al. Among authors: bello e. Gastroenterology. 2023 Oct;165(4):874-890.e10. doi: 10.1053/j.gastro.2023.05.038. Epub 2023 May 30. Gastroenterology. 2023. PMID: 37263309
Pattern of Clinical and Laboratory Presentation of Cerebral Malaria among Children in Nigeria.
Jegede TO, Oseni SB, Okeniyi JAO, Kuti BP, Adegoke SA, Salau QA, Bello EO, Jegede TO, Kareem AJ, Oyelami OA, Samuel IB, Oluwatuyi KO, Ekogiawe FT, Obasohan SE, Abazu IS, Babalola EO. Jegede TO, et al. Among authors: bello eo. J Glob Infect Dis. 2024 Mar 18;16(1):5-12. doi: 10.4103/jgid.jgid_100_23. eCollection 2024 Jan-Mar. J Glob Infect Dis. 2024. PMID: 38680759 Free PMC article.
Model-based closed-loop control of thalamic deep brain stimulation.
Tian Y, Saradhi S, Bello E, Johnson MD, D'Eleuterio G, Popovic MR, Lankarany M. Tian Y, et al. Among authors: bello e. Front Netw Physiol. 2024 Apr 8;4:1356653. doi: 10.3389/fnetp.2024.1356653. eCollection 2024. Front Netw Physiol. 2024. PMID: 38650608 Free PMC article.
Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide.
Matteo C, Orienti I, Eramo A, Zeuner A, Ferrari M, Passoni A, Bagnati R, Ponzo M, Bello E, Zucchetti M, Frapolli R. Matteo C, et al. Among authors: bello e. Pharmaceutics. 2024 Mar 12;16(3):387. doi: 10.3390/pharmaceutics16030387. Pharmaceutics. 2024. PMID: 38543281 Free PMC article.
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.
Lofiego MF, Piazzini F, Caruso FP, Marzani F, Solmonese L, Bello E, Celesti F, Costa MC, Noviello T, Mortarini R, Anichini A, Ceccarelli M, Coral S, Di Giacomo AM, Maio M, Covre A; EPigenetic Immune-oncology Consortium Airc (EPICA) investigators. Lofiego MF, et al. Among authors: bello e. J Transl Med. 2024 Mar 1;22(1):223. doi: 10.1186/s12967-024-05040-x. J Transl Med. 2024. PMID: 38429759 Free PMC article.
167 results